pg2 lyo.
Cancer-related Fatigue
PhytoHealth CorporationPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Cancer-related Fatigue cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide PhytoHealth Corporation | Phase 2 | B |
Epirubicin PhytoHealth Corporation | Phase 2 | B |
ASTRAGALUS MEMBRANACEUS ROOT POLYSACCHARIDES PhytoHealth Corporation | Phase 2 | B |
Codonopsis Zhejiang Provincial People's Hospital | N/A | D |
Zhengyuan Capsules Qiang Fu | Phase 4 | NR |
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →